Islet Cell Tumor
📧 Sign up to get email alerts when something new happens for Islet Cell Tumor.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2019-12-26Clinical Trial Update: Combination Chemotherapy and Bevacizumab in Treating Patients With Advanced Neuroendocrine Tumors [Phase 2, Phase 3]
A phase 2/3 trial evaluating combination chemotherapy with bevacizumab in advanced neuroendocrine tumors has been terminated; results were p…
-
CLINICAL_TRIALS trial_result · 2016-06-21Clinical Trial Update: Radiolabeled Octreotide in Treating Children With Advanced or Refractory Solid Tumors [Phase 1]
This Phase 1 trial update assesses the safety and feasibility of radiolabeled octreotide in pediatric patients with advanced or refractory s…
-
CLINICAL_TRIALS trial_result · 2015-06-04Clinical Trial Update: AMG 706 and Octreotide in Treating Patients With Low-Grade Neuroendocrine Tumors [Phase 2]
Phase 2 trial evaluating AMG 706 (motesanib) with octreotide in low-grade neuroendocrine tumors has completed enrollment and results were po…
-
CLINICAL_TRIALS trial_result · 2014-07-02Clinical Trial Update: Indium In 111 Pentetreotide in Treating Patients With Refractory Cancer [Phase 1]
Phase 1 trial evaluating Indium-111 pentetreotide in patients with refractory cancer across multiple tumor types. The study status is termin…
-
CLINICAL_TRIALS trial_result · 2014-01-17Clinical Trial Update: 68Ga-DOTATATE PET Scan Imaging in Patients With Neuroendocrine Tumors [Phase 1, Phase 2]
Phase 1/2 clinical trial evaluating 68Ga-DOTATATE PET imaging in patients with neuroendocrine tumors to assess diagnostic performance.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2013-08-07Clinical Trial Update: Capecitabine and Streptozocin With or Without Cisplatin in Treating Patients With Unresectable or Metastatic Neuroendocrine Tumors [Phase 2]
Phase 2 trial evaluating capecitabine and streptozocin with or without cisplatin in unresectable or metastatic neuroendocrine tumors has com…
-
CLINICAL_TRIALS trial_result · 2013-05-01Clinical Trial Update: Yttrium Y 90 SMT 487 in Treating Patients With Refractory or Recurrent Cancer [Phase 1]
Phase 1 trial evaluating Yttrium-90 SMT-487 in patients with refractory or recurrent cancers across multiple tumor types; the study has comp…
-
CLINICAL_TRIALS trial_result · 2013-01-31Clinical Trial Update: PS-341 in Treating Patients With Metastatic Neuroendocrine Tumors [Phase 2]
Phase 2 trial of PS-341 (bortezomib) in metastatic neuroendocrine tumors has completed enrollment with status reported as completed.
-
CLINICAL_TRIALS trial_result · 2012-09-07Clinical Trial Update: Phase II Study of Sunitinib Malate Following Hepatic Artery Embolization [Phase 2]
Phase II study evaluating sunitinib malate after hepatic artery embolization in neuroendocrine and islet cell tumors; the trial is completed…